DIMETAPP EXTRA STRENGTH 10 MG / 5 ML
PHENYLEPHRINE HYDROCHLORIDE : 10 MG / 5 ML BROMPHENIRAMINE MALEATE : 4 MG / 5 ML · DIN 02245075 · FOUNDATION CONSUMER BRANDS, LLC
Health Canada status: CANCELLED POST MARKET
What is DIMETAPP EXTRA STRENGTH?
DIMETAPP EXTRA STRENGTH 10 MG / 5 ML contains PHENYLEPHRINE HYDROCHLORIDE : 10 MG / 5 ML BROMPHENIRAMINE MALEATE : 4 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 02245075, held by FOUNDATION CONSUMER BRANDS, LLC, supplied as SYRUP for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 20-Dec-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02245075 |
|---|---|
| Brand name | DIMETAPP EXTRA STRENGTH |
| Generic / active ingredient | PHENYLEPHRINE HYDROCHLORIDE : 10 MG / 5 ML BROMPHENIRAMINE MALEATE : 4 MG / 5 ML |
| Manufacturer | FOUNDATION CONSUMER BRANDS, LLC |
| Strength | 10 MG / 5 ML |
| Dosage form | SYRUP |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R01BA53 PHENYLEPHRINE, COMBINATIONS |
| AHFS class | 04:04.20 ; 12:12.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 20-Dec-2021 |
| Original market date | 2002-08-01 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02245075 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2245075 |
| Brand name | DIMETAPP EXTRA STRENGTH |
| Active ingredient / INN | PHENYLEPHRINE HYDROCHLORIDE : 10 MG / 5 ML BROMPHENIRAMINE MALEATE : 4 MG / 5 ML |
| ATC code | R01BA53 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R01 |
| AHFS class | 04:04.20 ; 12:12.04 |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | FOUNDATION CONSUMER BRANDS, LLC |
Which pack is which?
| Strength on the label | 10 MG / 5 ML |
|---|---|
| Dosage form | SYRUP |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
What can be used instead?
Other Canadian products sharing ATC code R01BA53 PHENYLEPHRINE, COMBINATIONS. 0 of 24 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACTIFED PE | 4 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | CANCELLED PRE MARKET | DIN 02273845 |
| CHILDREN'S BENADRYL-D SYRUP | 12.5 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | CANCELLED POST MARKET | DIN 02280612 |
| COLD & STUFFY NOSE | 2.5 MG / 5 ML | LIQUID | ACCUDIAL PHARMACEUTICAL INC | CANCELLED POST MARKET | DIN 02328402 |
| COLD LIQUID | 2 MG / 5 ML | SOLUTION | TANTA PHARMACEUTICALS INC | DORMANT | DIN 02267411 |
| COLD LIQUID | 2 MG / 5 ML | SOLUTION | ARA-AVANTI RX ANALYTICS INC | CANCELLED PRE MARKET | DIN 02468212 |
| COLD LIQUID GRAPE FLAVOUR | 2 MG / 5 ML | SOLUTION | CELLCHEM PHARMACEUTICALS INC. | DORMANT | DIN 02315475 |
| COLD SYRUP | 5 MG / 5 ML | SYRUP | JAMP PHARMA CORPORATION | DORMANT | DIN 02266180 |
| DIMETAPP | 5 MG / 5 ML | SYRUP | FOUNDATION CONSUMER BRANDS, LLC | CANCELLED POST MARKET | DIN 02243980 |
| DIMETAPP CHEWABLES FOR KIDS | 2.5 MG | TABLET (CHEWABLE) | PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 02277239 |
| DIMETAPP ORAL INFANT COLD DROPS | 0.5 MG | LIQUID | WYETH CONSUMER HEALTHCARE INC. | CANCELLED POST MARKET | DIN 02243945 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.